Is Ketamine Safe? What Clinical Screening Actually Checks For

The honest answer is: for the right person, provider-supervised ketamine has a well-characterized safety profile built on 60 years of clinical use.

The more complete answer is: not everyone is the right person, which is exactly why the screening exists.

What gets evaluated before approval?

Cardiovascular health. Ketamine transiently raises heart rate and blood pressure. Patients with significant uncontrolled cardiovascular conditions are not appropriate candidates. This is evaluated before anything is prescribed.

Psychiatric history. Certain psychiatric histories — including personal or family history of specific psychotic conditions — represent contraindications. The screening asks directly and does not skip this.

Current medications. Some medication combinations require careful review. Your provider looks at what you are taking before making any recommendation.

Substance use history. Assessed individually. Not an automatic disqualifier but evaluated thoroughly.

The fact that not everyone is approved is the safety feature working correctly. A program that approves everyone is not a clinical program.

What about the session itself?

Sessions at Empathetix are provider-supervised. You are not alone. The clinical environment is controlled. Dosing is measured. The experience is monitored from start to finish.

No program is without individual risk. Your provider discusses your specific risk profile with you before anything is scheduled. That conversation is part of the protocol — not an afterthought.

For informational purposes only — not medical advice. Results vary and are not guaranteed. All protocols require provider evaluation and approval before
anything is prescribed. Compounded medications are not FDA-approved finished drug products. Not all patients will be approved for treatment. Medical emergency? Call 911.

© Empathetix Wellness · empathetix.com ·
(801) 804-3166 · info@empathetix.com